# MAG

## Overview
The MAG gene encodes the myelin-associated glycoprotein, a type I transmembrane protein that plays a pivotal role in the nervous system. This protein is primarily involved in the maintenance and stability of myelinated axons, acting as a critical component of the myelin sheath. MAG is characterized by its structure, which includes five immunoglobulin-like domains, and it functions as a bidirectional signaling molecule, facilitating interactions between myelin and axons. It is known for its role in inhibiting neurite outgrowth and maintaining axon-myelin spacing, which is essential for proper nerve function. The protein's interactions with axonal receptors, such as gangliosides and Nogo receptors, underscore its importance in neuroprotection and axonal health. Alterations in MAG expression or function have been associated with various neurological conditions, highlighting its clinical significance in both the central and peripheral nervous systems (Pronker2016Structural; Schnaar2009Myelin‐associated; Schachner2000Multiple).

## Structure
The myelin-associated glycoprotein (MAG) is a type I transmembrane protein that plays a crucial role in the nervous system. Its primary structure includes five immunoglobulin-like (Ig) domains in its extracellular segment, with domains Ig3 and Ig4 being conventional C2-type domains, while Ig1 has a V-type Ig fold, and Ig2 and Ig5 have C1-type folds (Pronker2016Structural; Pedraza1990The). The secondary structure of MAG is characterized by beta-sheets and alpha-helices, typical of immunoglobulin domains (Pedraza1990The).

The tertiary structure of MAG reveals an extended conformation with limited inter-domain flexibility, differing from the Ig-horseshoe folding seen in other neuronal adhesion molecules (Pronker2016Structural). MAG can form homodimers, which is significant for its function in maintaining myelin-axon spacing and inhibiting neurite outgrowth (Pronker2016Structural).

Post-translational modifications of MAG include N-linked glycosylation and palmitylation, which are crucial for its function. Glycosylation occurs at multiple sites, including the dimerization interface, while palmitylation involves a thioester linkage in the membrane-spanning segment (Pronker2016Structural; Pedraza1990The). MAG exists in two isoforms, L-MAG and S-MAG, which differ in their cytoplasmic segments due to alternative splicing (Pedraza1990The).

## Function
The myelin-associated glycoprotein (MAG) is a crucial component in the nervous system, primarily involved in maintaining the stability and integrity of myelinated axons. MAG is expressed on the innermost layer of myelin sheaths, where it interacts with axonal receptors to stabilize axon-myelin units. It binds to specific neuronal glycolipids, such as gangliosides GD1a and GT1b, which are essential for axon-myelin stability and function (Schnaar2009Myelin‐associated; Pan2005Myelinassociated).

MAG plays a significant role in regulating the axon cytoskeleton by influencing neurofilament phosphorylation, which affects neurofilament spacing and axon caliber, thereby supporting axon survival and function (Schnaar2009Myelin‐associated; Pan2005Myelinassociated). It is also involved in defining the distribution of axon molecules at nodes of Ranvier, which are critical for efficient nerve signal transmission (Pan2005Myelinassociated).

In addition to its structural roles, MAG provides neuroprotective effects, safeguarding axons from acute toxic insults through a ganglioside-dependent mechanism (Mehta2009MyelinAssociated). This protective function is crucial for maintaining axonal health and preventing degeneration in both the central and peripheral nervous systems (Schachner2000Multiple; Fruttiger1995Crucial).

## Clinical Significance
Mutations or alterations in the expression of the MAG gene, which encodes the myelin-associated glycoprotein, have been implicated in several neurological conditions. Although direct mutations in the MAG gene have not been conclusively linked to specific human diseases, its role in maintaining myelin integrity suggests potential clinical significance in demyelinating diseases. In the peripheral nervous system (PNS), MAG is crucial for long-term myelin maintenance. MAG null mutants exhibit degenerative changes such as 'onion bulbs' and myelin tomacula, which are associated with axonal degeneration. These features are similar to those observed in inherited peripheral neuropathies like Charcot-Marie-Tooth disease, although a direct link to the human MAG gene has not been established (Schachner2000Multiple).

In the central nervous system (CNS), MAG deficiency leads to dystrophy of distal oligodendrocyte processes, a condition reminiscent of 'dying-back oligodendrogliopathy' seen in demyelinating diseases such as multiple sclerosis. The expression of MAG is downregulated by pro-inflammatory cytokines, indicating its importance in maintaining oligodendrocyte integrity (Schachner2000Multiple). Transgenic studies have shown that expressing a MAG transgene can compensate for the lack of endogenous MAG, maintaining normal myelin morphology, highlighting its potential therapeutic significance (Schachner2000Multiple).

## Interactions
Myelin-associated glycoprotein (MAG) participates in several critical interactions within the nervous system. MAG interacts with axonal receptors, particularly gangliosides such as GD1a and GT1b, which are crucial for axon-myelin stability. These interactions are essential for maintaining the structural integrity of myelin and inhibiting axon regeneration (Schnaar2009Myelin‐associated). MAG also binds to Nogo receptors, specifically NgR1 and NgR2, which mediate the inhibition of axon outgrowth. This interaction is part of a complex network that includes other axon regeneration inhibitors like oligodendrocyte-myelin glycoprotein (OMgp) (Schnaar2009Myelin‐associated).

MAG's interaction with gangliosides involves its N-terminal V-type Ig domain, which binds to sialic acids, playing a role in neurite outgrowth inhibition (Pronker2016Structural). The dimerization of MAG, facilitated by its Ig4 and Ig5 domains, is crucial for its function in inhibiting neurite outgrowth and maintaining myelin-axon spacing (Pronker2016Structural). These interactions highlight MAG's role in both axon-to-myelin and myelin-to-axon signaling, contributing to its function as a bidirectional signaling molecule (Pronker2016Structural).


## References


[1. (Pedraza1990The) L Pedraza, G C Owens, L A Green, and J L Salzer. The myelin-associated glycoproteins: membrane disposition, evidence of a novel disulfide linkage between immunoglobulin-like domains, and posttranslational palmitylation. The Journal of cell biology, 111(6):2651–2661, December 1990. URL: http://dx.doi.org/10.1083/jcb.111.6.2651, doi:10.1083/jcb.111.6.2651. This article has 84 citations.](https://doi.org/10.1083/jcb.111.6.2651)

[2. (Schachner2000Multiple) Melitta Schachner and Udo Bartsch. Multiple functions of the myelin-associated glycoprotein mag (siglec-4a) in formation and maintenance of myelin. Glia, 29(2):154–165, January 2000. URL: http://dx.doi.org/10.1002/(SICI)1098-1136(20000115)29:2<154::AID-GLIA9>3.0.CO;2-3, doi:10.1002/(sici)1098-1136(20000115)29:2<154::aid-glia9>3.0.co;2-3. This article has 251 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/(SICI)1098-1136(20000115)29:2)

[3. (Pan2005Myelinassociated) Baohan Pan, Susan E. Fromholt, Ellen J. Hess, Thomas O. Crawford, John W. Griffin, Kazim A. Sheikh, and Ronald L. Schnaar. Myelin-associated glycoprotein and complementary axonal ligands, gangliosides, mediate axon stability in the cns and pns: neuropathology and behavioral deficits in single- and double-null mice. Experimental Neurology, 195(1):208–217, September 2005. URL: http://dx.doi.org/10.1016/j.expneurol.2005.04.017, doi:10.1016/j.expneurol.2005.04.017. This article has 158 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.expneurol.2005.04.017)

[4. (Fruttiger1995Crucial) M. Fruttiger, D. Montag, M. Schachner, and R. Martini. Crucial role for the myelin‐associated glycoprotein in the maintenance of axon‐myelin integrity. European Journal of Neuroscience, 7(3):511–515, March 1995. URL: http://dx.doi.org/10.1111/j.1460-9568.1995.tb00347.x, doi:10.1111/j.1460-9568.1995.tb00347.x. This article has 189 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1111/j.1460-9568.1995.tb00347.x)

[5. (Mehta2009MyelinAssociated) Niraj R. Mehta, Thien Nguyen, John W. Bullen, John W. Griffin, and Ronald L. Schnaar. Myelin-associated glycoprotein (mag) protects neurons from acute toxicity using a ganglioside-dependent mechanism. ACS Chemical Neuroscience, 1(3):215–222, December 2009. URL: http://dx.doi.org/10.1021/cn900029p, doi:10.1021/cn900029p. This article has 30 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/cn900029p)

[6. (Pronker2016Structural) Matti F. Pronker, Suzanne Lemstra, Joost Snijder, Albert J. R. Heck, Dominique M. E. Thies-Weesie, R. Jeroen Pasterkamp, and Bert J. C. Janssen. Structural basis of myelin-associated glycoprotein adhesion and signalling. Nature Communications, December 2016. URL: http://dx.doi.org/10.1038/ncomms13584, doi:10.1038/ncomms13584. This article has 103 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ncomms13584)

[7. (Schnaar2009Myelin‐associated) Ronald L. Schnaar and Pablo H.H. Lopez. Myelin‐associated glycoprotein and its axonal receptors. Journal of Neuroscience Research, 87(15):3267–3276, January 2009. URL: http://dx.doi.org/10.1002/jnr.21992, doi:10.1002/jnr.21992. This article has 117 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jnr.21992)